Pashayan, Nora
Pharoah, Paul DP
Schleutker, Johanna
Talala, Kirsi
Tammela, Teuvo LJ
Määttänen, Liisa
Harrington, Patricia
Tyrer, Jonathan
Eeles, Rosalind
Duffy, Stephen W
Auvinen, Anssi
Article History
Received: 2 April 2015
Revised: 2 July 2015
Accepted: 11 July 2015
First Online: 20 August 2015
Competing interests
: TT has received grants and fees from Astellas, Janssen, Orion Pharma, and AMGEN. RE declares receiving educational grant from GenProbe/Vista Diagnostics/Illumina; Honorarium & expenses to UK Cancer Convention October 2012 from Succint Communications; Medical Education support to GU-ASCO meeting February 2013 from Janssen. All the remaining authors declare no conflict of interest.